Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

Updated NICE guidance on hypertension published

NICE has published an update to its guideline on the diagnosis and management of hypertension in adults (NG136). The new guidance replaces CG127, published in...Read more

NICE publishes draft guideline on use of medical cannabis

Following a review of clinical and cost-effectiveness, NICE has published draft guidance for consultation on the use of cannabis-based medicinal products for...Read more

New antimicrobial prescribing guidance for impetigo

NICE is consulting on draft guidance on the treatment of impetigo. The recommendations will form part of NICE and Public Health England’s series of...Read more

Fast-acting insulin aspart approved for children

The European Commission has granted an extension to the indication of Fiasp (fast-acting insulin aspart). It is now approved for the treatment of diabetes in...Read more

Toolkit launched for progressive neurological conditions

NHS England has launched a new toolkit to support commissioners to improve services for patients with progressive neurological conditions. The NHS RightCare...Read more

Featured Articles

A comprehensive guide to the management of anaemia
A systematic approach to evaluation and investigation is key to the successful management of anaemia. This article examines the classification of anaemia, its underlying causes and clinical manifestations, and the range of treatments available.
Click here to view

Impact of the Avastin case on prescribing medicines off-label
In 2018, the High Court ruled that CCGs can prescribe bevacizumab (Avastin) off-label for wet age-related macular degeneration (wet AMD). This article discusses the background to the case and its wider implications for drug licensing and clinical practice.
Click here to view

Monoclonal antibodies for the treatment of plaque psoriasis
There is now a wide range of monoclonal antibody therapies to choose from for the treatment of severe plaque psoriasis. This article examines their mechanisms of action, place in therapy, efficacy and safety.
Click here to view

Web design and marketing agency Leamington Spa